Sign In
Buy ABT
$90.53
+2.76 (+3.14%)
At Close: Jun 23, 2026
Better Dividend King: Johnson & Johnson vs. Abbott Laboratories
11:42am, Thursday, 05'th May 2022 The Motley Fool
Where's the safer place to park your money?
Better Dividend King: Johnson & Johnson vs. Abbott Laboratories
07:42am, Thursday, 05'th May 2022
Where's the safer place to park your money?
Want $2,000 in Passive Income? Invest $10,000 in This Cathie Wood Dividend Stock and Wait 5 Years
03:00pm, Saturday, 30'th Apr 2022 The Motley Fool
This dividend stock is one of the few holdings that Cathie Wood and Warren Buffett have in common.
The Near Perfect Portfolio For The Good Times And Bad
01:00pm, Saturday, 30'th Apr 2022 Seeking Alpha
With index investing, there's no escape from a roller coaster ride. For most people, especially retirees, it's very difficult to tolerate large and deep drawdowns.
The Zacks Analyst Blog Highlights Visa, Walt Disney, Abbott Laboratories, Nike and United Parcel Service
09:26am, Friday, 29'th Apr 2022 Zacks Investment Research
Visa, Walt Disney, Abbott Laboratories, Nike and United Parcel Service have been included in this Analyst Blog.
Top Analyst Reports for Visa, Walt Disney & Abbott
09:20pm, Thursday, 28'th Apr 2022 Zacks Investment Research
Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), The Walt Disney Company (DIS), and Abbott Laboratories (ABT).
The 5 Best Healthcare Stocks To Own Right Now
02:41pm, Thursday, 28'th Apr 2022
People will always need medical treatment regardless of what is going on with the economy, which makes stocks in the healthcare sector consistently reliable investments.
Can a decades-old antidepressant keep COVID-19 patients out of the hospital?
01:00pm, Thursday, 28'th Apr 2022 MarketWatch
It's one of several generic drugs that's being tested as a way to treat the virus.
EXCLUSIVE: Verano CIO Aaron Miles Says Company Is 'Strategically Building' As Crucial Markets Come Online
03:12pm, Tuesday, 26'th Apr 2022 Benzinga
Verano Holdings Corp (OTC: VRNOF) CIO Aaron Miles tells Benzinga that he and the Chicago-based MSO have been able to grow in the often tumultuous cannabis market through market experience and strategi
Here's the Worst News for Abbott Right Now (and Why Investors Shouldn't Worry)
10:00am, Tuesday, 26'th Apr 2022 The Motley Fool
There's some sunshine around the dark cloud.
Here's the Worst News for Abbott Right Now (and Why Investors Shouldn't Worry)
06:00am, Tuesday, 26'th Apr 2022
There's some sunshine around the dark cloud.
3 Medical Product Stocks Poised to Beat This Earnings Season
11:54am, Monday, 25'th Apr 2022 Zacks Investment Research
Medical product companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how ALC, ZBH and CSII are poised ahead of their earnings releases.
3 Medical Product Stocks Poised to Beat This Earnings Season
09:02am, Monday, 25'th Apr 2022
Medical product companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how ALC, ZBH and CSII are poised ahead of their earnings releases.
BME: Good Times, Bad Times, A Fund For All Times
04:50am, Sunday, 24'th Apr 2022 Seeking Alpha
BME focuses on an underlying portfolio of healthcare stocks with a covered call strategy. Click here to see BME's holdings, performance, and my recommendation.
The Dividend Kings Ranked By Quality Score
01:00pm, Saturday, 23'rd Apr 2022 Seeking Alpha
Dividend Kings have a remarkable track record of 50 or more years of increasing dividend payouts. Click here to learn more.
